IDH1 and myeloproliferative neoplasm: Of importance in MPN are the observations that mutations in epigenetic regulators are associated with adverse clinical outcomes and the specific role of IDH1/2 mutations in promoting MPN progression and transformation (9–12, 14, 24, 34, 35).